Hearing on anti-China bills back on amid continued pressure on WuXi stocks 

A select committee hearing on anti-China biotech legislation is back on the calendar and likely to add to pressure on shares of WuXi AppTec and WuXi Biologics.

The House Select Committee on the Chinese Communist Party has rescheduled the hearing, which focuses on the Biosecure Act (H.R. 7085). The hearing, titled “Growing Stakes: The Bioeconomy and American National Security,” was originally scheduled for Feb. 13 but was postponed because of a threatened snowstorm. It will be held in Washington on March 7...